Insulin Schemes for Type 2 Diabetes Control

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

NPH insulin

NPH insulin twice daily, 2/3 in the morning and 1/3 in the night. A correctional dose of lispro insulin will be given for any blood glucose \>180 mg/dL.

DRUG

Glargine and Lispro insulin

Half of the total Glargine and Lispro insulin dose will be given as glargine once daily, either in the morning or in the evening, depending on when the patient was enrolled. The other half of the total daily insulin dose was given as Lispro; doses were divided equally between breakfast, lunch, and dinner.

Trial Locations (1)

37680

Hospital General de León, León

All Listed Sponsors
lead

Universidad de Guanajuato

OTHER

NCT03350984 - Insulin Schemes for Type 2 Diabetes Control | Biotech Hunter | Biotech Hunter